Pelthos Therapeutics Inc.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-1.8M | $-2.6M | $-4.0M | $-1.4M | $-953.3K | $-966.6K |
| Depreciation & Amortization | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | $459.0K | $292.6K | $791.2K | $342.4K | $327.3K | $272.2K |
| Net Cash from Operating Activities | $-3.0M | $-2.0M | $-356.8K | $-257.2K | $-193.6K | $-173.4K |
| Investing Activities | ||||||
| Capital Expenditures | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $1.6M | $5.7M | $430.4K | $198.1K | $226.9K | $166.9K |
| Net Change in Cash | — | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — | — |